Drug and Gene Delivery Systems Market Is Registering a Healthy 6% CAGR Between 2017 and 2025
The global market for drug and gene delivery systems features a largely consolidated vendor landscape with only a handful companies accounting for a dominant share in the overall market, observes Transparency Market Research in a recent report. So as to gain a larger hold on the market, companies are putting more emphasis on offering advanced products, ploughing more resources into R&D activities, and seeking new ways of expanding their product portfolios. Thus instances of strategic collaborations and partnerships in the...
View full press release